— Know what they know.
Not Investment Advice

ALIM NASDAQ

Alimera Sciences, Inc.
1W: +0.2% 1M: -0.9% 3M: +81.6% 1Y: +73.7% 3Y: +0.9%
$5.54
Last traded 2024-09-18 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $301.3M mcap · 13M float · 6.88% daily turnover

Cash Flow Trends

Operating Cash Flow
-$14M -43.0% ▼
Capital Expenditures
$76M -29520.4% ▼
5Y CAGR: +236.5%
Free Cash Flow
-$90M -777.7% ▼
Dividends Paid
$1M +0.0% ▲
Buybacks
$314K +0.0% ▲
Net Change in Cash
$7M +160.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$10M-$5M-$4M-$18M-$20M
Depreciation & Amort.$3M$3M$3M$3M$9M
Stock-Based Comp.$2M$1M$997K$910K$1M
Change in Working Capital-$181K-$1M-$1M$3M-$16M
Other Non-Cash Items$921K$498K-$2M$2M$11M
Operating Cash Flow-$4M-$2M-$3M-$10M-$14M
— Investing Activities —
Capital Expenditures-$174K-$620K-$621K-$255K-$76M
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0-$75M
Investing Cash Flow-$174K-$620K-$621K-$255K-$76M
— Financing Activities —
Net Debt Issuance-$33K$4M-$221K-$289K$22M
Stock Repurchased$0$0$0$0-$314K
Dividends Paid$0$0$0$0-$1M
Other Financing$0-$19K-$40K-$98K-$4M
Financing Cash Flow$869K$4M$10M-$302K$96M
Net Change in Cash-$4M$2M$5M-$11M$7M
Cash End of Period$9M$11M$17M$5M$12M
Free Cash Flow-$4M-$3M-$4M-$10M-$90M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms